Volume status and diuretic therapy in systolic heart failure and the detection of early abnormalities in renal and tubular function.

[1]  D. J. Veldhuisen,et al.  Both in‐ and out‐hospital worsening of renal function predict outcome in patients with heart failure: results from the Coordinating Study Evaluating Outcome of Advising and Counseling in Heart Failure (COACH) , 2009, European journal of heart failure.

[2]  G. Lip,et al.  Performing repeated noninvasive bedside measures of volume response to intravenous furosemide in acute pulmonary edema: a feasibility assessment. , 2009, Cardiovascular therapeutics.

[3]  G. Navis,et al.  Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. , 2009, Journal of the American College of Cardiology.

[4]  Gary S Francis,et al.  Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. , 2009, Journal of the American College of Cardiology.

[5]  D. J. Veldhuisen,et al.  Differential associations between renal function and “modifiable” risk factors in patients with chronic heart failure , 2009, Clinical Research in Cardiology.

[6]  D. J. Veldhuisen,et al.  Urinary neutrophil gelatinase associated lipocalin (NGAL), a marker of tubular damage, is increased in patients with chronic heart failure , 2008, European journal of heart failure.

[7]  S. Waikar,et al.  Biomarkers for the Diagnosis of Acute Kidney Injury , 2008, Nephron Clinical Practice.

[8]  R. Starling,et al.  557 Prompt reduction in Intra‐Abdominal Pressure following large‐volume mechanical fluid removal improves renal insufficiency in refractory decompensated Heart Failure , 2008 .

[9]  V. Vallon,et al.  Adenosine and kidney function: Potential implications in patients with heart failure , 2008, European journal of heart failure.

[10]  M. Metra,et al.  Worsening renal function in patients hospitalised for acute heart failure: Clinical implications and prognostic significance , 2008, European journal of heart failure.

[11]  J. Bonventre,et al.  Biomarkers of acute kidney injury. , 2008, Annual review of pharmacology and toxicology.

[12]  A. Maisel,et al.  State-of-the-Art PaperNatriuretic Peptides , 2007 .

[13]  John G F Cleland,et al.  Worsening renal function and prognosis in heart failure: systematic review and meta-analysis. , 2007, Journal of cardiac failure.

[14]  D. J. Veldhuisen,et al.  Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction , 2007, European journal of heart failure.

[15]  K. Mori,et al.  Dual action of neutrophil gelatinase-associated lipocalin. , 2007, Journal of the American Society of Nephrology : JASN.

[16]  A. Maisel,et al.  Natriuretic peptides. , 2007, Journal of the American College of Cardiology.

[17]  K. Dickstein,et al.  The effect of altering haemodynamics on the plasma concentrations of natriuretic peptides in heart failure , 2006, European journal of heart failure.

[18]  Joseph V Bonventre,et al.  Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury. , 2006, American journal of physiology. Renal physiology.

[19]  P. Sobotka,et al.  Early ultrafiltration in patients with decompensated heart failure and diuretic resistance. , 2005, Journal of the American College of Cardiology.

[20]  J. Soler‐Soler,et al.  Clinical and neurohumoral consequences of diuretic withdrawal in patients with chronic, stabilized heart failure and systolic dysfunction , 2005, European journal of heart failure.

[21]  Qing Ma,et al.  Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery , 2005, The Lancet.

[22]  J. Sellgren,et al.  Differential effects of human atrial natriuretic peptide and furosemide on glomerular filtration rate and renal oxygen consumption in humans , 2004, Intensive Care Medicine.

[23]  M. Domanski,et al.  Diuretic use, progressive heart failure, and death in patients in the Studies Of Left Ventricular Dysfunction (SOLVD). , 2003, Journal of the American College of Cardiology.

[24]  Lars Rydén,et al.  Continous haemodynamic monitoring during withdrawal of diuretics in patients with congestive heart failure , 2002 .

[25]  L. Rydén,et al.  Continuous haemodynamic monitoring during withdrawal of diuretics in patients with congestive heart failure. , 2002, European heart journal.

[26]  A. Charlesworth,et al.  Renal function, neurohormonal activation, and survival in patients with chronic heart failure. , 2000, Circulation.

[27]  M. Fisher,et al.  Effects of BG9719 (CVT-124), an A1-adenosine receptor antagonist, and furosemide on glomerular filtration rate and natriuresis in patients with congestive heart failure. , 2000, Journal of the American College of Cardiology.

[28]  M. Brezis,et al.  Determinants of intrarenal oxygenation. I. Effects of diuretics. , 1994, The American journal of physiology.

[29]  B. Brenner,et al.  Role of the kidney in congestive heart failure. , 2009, Acta medica Scandinavica. Supplementum.

[30]  R. G. Price,et al.  Urinary N-acetyl- beta-D-glucosaminidase activities in patients with renal disease. , 1975, British medical journal.

[31]  M. Maxwell,et al.  RENAL VENOUS PRESSURE IN CHRONIC CONGESTIVE HEART FAILURE. , 1950, The Journal of clinical investigation.